{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:22:34Z","timestamp":1791588154691,"version":"4.3.4"},"reference-count":270,"publisher":"The Japan Society of Coloproctology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2026,1,25]]},"DOI":"10.23922\/jarc.2025-071","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T22:09:36Z","timestamp":1769292576000},"page":"135-168","source":"Crossref","is-referenced-by-count":3,"title":["Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2024 for the Clinical Practice of Inflammatory Bowel Disease-Associated Intestinal Neoplasia (English Version)"],"prefix":"10.23922","volume":"10","author":[{"given":"Soichiro","family":"Ishihara","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Tanaka","sequence":"additional","affiliation":[{"name":"JA Onomichi General Hospital Onomichi and Department of Gastroenterology, Hiroshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Uraoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Medicine, Gunma University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Saito","sequence":"additional","affiliation":[{"name":"Endoscopy Division, National Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takamaru","sequence":"additional","affiliation":[{"name":"Endoscopy Division, National Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakase","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Naganuma","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Third Department of Internal Medicine, Kansai Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Hisamatsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyorin University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyorin University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine for Inflammatory Bowel Disease, University of Toyama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ikeuchi","sequence":"additional","affiliation":[{"name":"Division of Inflammatory Bowel Disease Surgery, Department of Gastroenterological Surgery, Hyogo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Uchino","sequence":"additional","affiliation":[{"name":"Division of Inflammatory Bowel Disease Surgery, Department of Gastroenterological Surgery, Hyogo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Okita","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Okabayashi","sequence":"additional","affiliation":[{"name":"Division of Colorectal Surgery, Department of Surgery, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Koganei","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen&apos;s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen&apos;s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Tohoku Rosai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Gastroenterology, Toyoshima Endoscopy Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijiro","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fukuoka University Chikushi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitaro","family":"Futami","sequence":"additional","affiliation":[{"name":"Department of Surgery, Matsunaga Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Fraternity Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunekazu","family":"Mizushima","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Dokkyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Watadani","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawachi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shimoda","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Sugai","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, International University of Health and Welfare Ichikawa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Library of Seirei Sakura Citizen Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Itabashi","sequence":"additional","affiliation":[{"name":"Saitama Saiseikai Kazo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Anzai","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kishikawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tohto Bunkyo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Shinagawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Tsushima","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Ajioka","sequence":"additional","affiliation":[{"name":"Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10009","reference":[{"key":"1","unstructured":"1. JSCCR Guidelines 2024 for the Clinical Practice of Inflammatory Bowel Disease-Associated Intestinal Neoplasia; 2024 (Japanese). Kanehara, Tokyo."},{"key":"2","unstructured":"2. Minds Guideline Development Manual 2020 ver. 3.0. Tokyo: Japan Council for Quality Health Care; 2020 (Japanese)."},{"key":"3","unstructured":"3. Harpaz N, Talbot IC. Colorectal cancer in idiopathic inflammatory bowel disease. Semin Diagn Pathol. 1996 Nov;13 (4):339-57."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001 Feb 15;91 (4):854-62.","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001 Apr;48 (4):526-35.","DOI":"10.1136\/gut.48.4.526"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Itzkowitz SH, Yio X. Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287 (1):G7-17.","DOI":"10.1152\/ajpgi.00079.2004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011 May;140 (6):1807-16.","DOI":"10.1053\/j.gastro.2011.01.057"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Saraggi D, Fassan M, Mescoli C, et al. The molecular landscape of colitis-associated carcinogenesis. Dig Liver Dis. 2017 Apr;49 (4):326-30.","DOI":"10.1016\/j.dld.2016.12.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983 Apr;14 (11):931-68.","DOI":"10.1016\/S0046-8177(83)80175-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Velayos FS, Loftus EV Jr, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology. 2006 May;130 (7):1941-9.","DOI":"10.1053\/j.gastro.2006.03.028"},{"key":"11","unstructured":"11. Schneider A, Stolte M. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Z Gastroenterol. 1993 Nov;31 (11):653-6."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Odze RD. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol. 1999;94 (7):1746-50.","DOI":"10.1111\/j.1572-0241.1999.01201.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Vieth M, Neumann H. Current issues in inflammatory bowel disease neoplasia. Histopathology. 2015 Dec;66 (1):37-48.","DOI":"10.1111\/his.12565"},{"key":"14","unstructured":"14. Odze RD, Riddell RH, Bosman FT, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC; 2010. Premalignant lesions of the digestive system; pp. 10-2, Bosman, FT, Carneiro, F, Hruban, RH, et al., eds."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. van Rheenen PF, Aloi M, Biron IA, et al. European Crohn&apos;s and colitis organisation topical review on transitional care in inflammatory bowel disease. J Crohns Colitis. 2017 Oct;11 (9):1032-8.","DOI":"10.1093\/ecco-jcc\/jjx010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tranter-Entwistle I, Mullaney TG, Noah K, et al. Long-term incidence of dysplasia and colorectal cancer in an ulcerative colitis population-based cohort. ANZ J Surg. 2020 Apr;90 (5):821-5.","DOI":"10.1111\/ans.15686"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Matsuoka H, Ikeuchi H, Uchino M, et al. Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort. Int J Colorectal Dis. 2013 Apr;28 (6):829-34.","DOI":"10.1007\/s00384-012-1592-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bogach J, Pond G, Eskicioglu C, et al. Age-related survival differences in patients with inflammatory bowel disease-associated colorectal cancer: a population-based cohort study. Inflamm Bowel Dis. 2019 Oct;25 (12):1957-65.","DOI":"10.1093\/ibd\/izz088"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kunovszki P, Milassin \u00c1, Gimesi-Orsz\u00e1gh J, et al. Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study. PLoS One. 2020 Mar;15 (5):e0233238.","DOI":"10.1371\/journal.pone.0233238"},{"key":"20","unstructured":"20. Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019 Apr;68 (suppl 3):S1-106."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Beaugerie L, Svrcek M, Seksik P, et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013 Oct;145 (1):166-75.e8.","DOI":"10.1053\/j.gastro.2013.03.044"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Torres J, Pineton de Chambrun G, Itzkowitz S, et al. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Ther. 2011 Jan;34 (5):497-508.","DOI":"10.1111\/j.1365-2036.2011.04753.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lutgens M, Vermeire S, Van Oijen M, et al. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015 Dec;13 (1):148-54.e1.","DOI":"10.1016\/j.cgh.2014.06.032"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Cohen-Mekelburg S, Schneider Y, Gold S, et al. Risk of early colorectal cancers needs to be considered in inflammatory bowel disease care. Dig Dis Sci. 2019 Oct;64 (8):2273-9.","DOI":"10.1007\/s10620-019-05554-1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hata K, Anzai H, Ikeuchi H, et al. Surveillance colonoscopy for ulcerative colitis-associated colorectal cancer offers better overall survival in real-world surgically resected cases. Am J Gastroenterol. 2019 Nov;114 (3):483-9.","DOI":"10.14309\/ajg.0000000000000117"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Heuschen UA, Hinz U, Allemeyer EH, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. 2001 Jan;120 (4):841-7.","DOI":"10.1053\/gast.2001.22434"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Navaneethan U, Jegadeesan R, Gutierrez NG, et al. Backwash ileitis and the risk of colon neoplasia in ulcerative colitis patients undergoing restorative proctocolectomy. Dig Dis Sci. 2013 Oct;58 (7):2019-27.","DOI":"10.1007\/s10620-013-2571-7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Stellingwerf ME, Bemelman WA, L\u00f6wenberg M, et al. A nationwide database study on colectomy and colorectal cancer in ulcerative colitis: what is the role of appendectomy? Colorectal Dis. 2021 Oct;23 (1):64-73.","DOI":"10.1111\/codi.15184"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Stellingwerf ME, de Koning MA, Pinkney T, et al. The risk of colectomy and colorectal cancer after appendectomy in patients with ulcerative colitis: a systematic review and meta-analysis. J Crohns Colitis. 2019 Oct;13 (3):309-18.","DOI":"10.1093\/ecco-jcc\/jjy163"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gordillo J, Cabr\u00e9 E, Garcia-Planella E, et al. Thiopurine therapy reduces the incidence of colorectal neoplasia in patients with ulcerative colitis. Data from the ENEIDA registry. J Crohns Colitis. 2015 Oct;9 (12):1063-70.","DOI":"10.1093\/ecco-jcc\/jjv145"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ol\u00e9n O, Erichsen R, Sachs MC, et al. Colorectal cancer in Crohn&apos;s disease: a Scandinavian population-based cohort study. Lancet Gastroenterol Hepatol. 2020 Oct;5 (5):475-84.","DOI":"10.1016\/S2468-1253(20)30005-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn&apos;s disease. Aliment Pharmacol Ther. 2006 Apr 15;23 (8):1097-104.","DOI":"10.1111\/j.1365-2036.2006.02854.x"},{"key":"33","unstructured":"33. Beaugerie L, Carrat F, Nahon S, et al. High Risk of Anal and Rectal Cancer in Patients with Anal and\/or Perianal Crohn&apos;s disease. Clin Gastroenterol Hepatol. 2018 Jun;16 (6):892-9.e2."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Watanabe T, Konishi T, Kishimoto J, et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011 May;17 (3):802-8.","DOI":"10.1002\/ibd.21365"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Burmer GC, Rabinovitch PS, Haggitt RC, et al. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology. 1992 Oct;103 (5):1602-10.","DOI":"10.1016\/0016-5085(92)91184-6"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Robles AI, Traverso G, Zhang M, et al. Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers. Gastroenterology. 2016 Jun;150 (4):931-43.","DOI":"10.1053\/j.gastro.2015.12.036"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Klampfer L. Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets. 2011 May;11 (4):451-64.","DOI":"10.2174\/156800911795538066"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019 Mar;114 (3):384-413.","DOI":"10.14309\/ajg.0000000000000152"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Magro F, Gionchetti P, Eliakim R, et al. European Crohn&apos;s and colitis organisation [ECCO]: third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1. J Crohns Colitis. 2017 Apr;11 (6) :649-70.","DOI":"10.1093\/ecco-jcc\/jjx008"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Annese V, Beaugerie L, Egan L, et al. European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohns Colitis. 2015 Nov;9 (11):945-65.","DOI":"10.1093\/ecco-jcc\/jjv141"},{"key":"41","unstructured":"41. The Japanese Society of Gastroenterology guideline, evidence-based clinical guidelines for inflammatory bowel disease (IBD). 2nd ed. The Japanese Society of Gastroenterology; 2020 [cited 2021 Dec 15]. Available from: https:\/\/www.jsge.or.jp\/files\/uploads\/ibd2020.pdf. Japanese."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Uchino M, Ikeuchi H, Hata K, et al. Intestinal cancer in patients with Crohn&apos;s disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2021 Nov;36 (2):329-36.","DOI":"10.1111\/jgh.15229"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Lyakhovich A, Gasche C. Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine. Aliment Pharmacol Ther. 2010 Jan 15;31 (2):202-9.","DOI":"10.1111\/j.1365-2036.2009.04195.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. O&apos;Connor A, Packey CD, Akbari M, et al. Mesalamine, but not sulfasalazine, reduces the risk of colorectal neoplasia in patients with inflammatory bowel disease: an agent-specific systematic review and meta-analysis. Inflamm Bowel Dis. 2015 Apr;21 (11):2562-9.","DOI":"10.1097\/MIB.0000000000000540"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Qiu X, Ma J, Wang K, et al. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis. Oncotarget. 2017 Jan 3;8 (1):1031-45.","DOI":"10.18632\/oncotarget.13715"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Bonovas S, Fiorino G, Lytras T, et al. Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017 Oct;45 (9):1179-92.","DOI":"10.1111\/apt.14023"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Zhao LN, Li JY, Yu T, et al. 5-aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis. PLoS One. 2014 Apr;9 (4):e94208.","DOI":"10.1371\/journal.pone.0094208"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol. 2005 Aug;100 (6):1345-53.","DOI":"10.1111\/j.1572-0241.2005.41442.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Akobeng AK, Gardener E. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn&apos;s disease. Cochrane Database Syst Rev. 2016 Jan;9:CD003715.","DOI":"10.1002\/14651858.CD003715.pub3"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Zhu Z, Mei Z, Guo Y, et al. Reduced risk of inflammatory bowel disease-associated colorectal neoplasia with use of thiopurines: a systematic review and meta-analysis. J Crohns Colitis. 2018 Apr;12 (5):546-58.","DOI":"10.1093\/ecco-jcc\/jjy006"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Lu MJ, Qiu XY, Mao XQ, et al. Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2018 Oct;47 (3):318-31.","DOI":"10.1111\/apt.14436"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Gong J, Zhu L, Guo Z, et al. Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis. PLoS One. 2013 Nov 28;8 (11):e81487.","DOI":"10.1371\/journal.pone.0081487"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Jess T, Lopez A, Andersson M, et al. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis. Clin Gastroenterol Hepatol. 2014 Nov;12 (11):1793-800.e1.","DOI":"10.1016\/j.cgh.2014.05.019"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Pardi DS, Loftus EV Jr, Kremers WK, et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003 Apr;124 (4):889-93.","DOI":"10.1053\/gast.2003.50156"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Eaton JE, Silveira MG, Pardi DS, et al. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol. 2011 Sep;106 (9):1638-45.","DOI":"10.1038\/ajg.2011.156"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Hansen JD, Kumar S, Lo WK, et al. Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis. Dig Dis Sci. 2013 Nov;58 (11):3079-87.","DOI":"10.1007\/s10620-013-2772-0"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Charkaoui M, Hajage D, Tubach F, et al. Impact of anti-tumour necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: nationwide French cohort study. J Crohns Colitis. 2022 Jul 14;16 (6):893-9.","DOI":"10.1093\/ecco-jcc\/jjab184"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Alkhayyat M, Abureesh M, Gill A, et al. Lower rates of colorectal cancer in patients with inflammatory bowel disease using anti-TNF therapy. Inflamm Bowel Dis. 2021 Jun 15;27 (7):1052-60.","DOI":"10.1093\/ibd\/izaa252"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Baars JE, Looman CW, Steyerberg EW, et al. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol. 2011 Feb;106 (2):319-28.","DOI":"10.1038\/ajg.2010.428"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010 Nov 20;376 (9754):1741-50.","DOI":"10.1016\/S0140-6736(10)61543-7"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Burr NE, Hull MA, Subramanian V. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease? World J Gastroenterol. 2016 Apr 7;22 (13):3679-86.","DOI":"10.3748\/wjg.v22.i13.3679"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Shah SC, Glass J, Giustino G, et al. Statin exposure is not associated with reduced prevalence of colorectal neoplasia in patients with inflammatory bowel disease. Gut Liver. 2019 Jan 15;13 (1):54-61.","DOI":"10.5009\/gnl18178"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Burr NE, Hull MA, Subramanian V. Folic acid supplementation may reduce colorectal cancer risk in patients with inflammatory bowel disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2017 Mar;51 (3):247-53.","DOI":"10.1097\/MCG.0000000000000498"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. L\u00f6fberg R, Brostr\u00f6m O, Karl\u00e9n P, et al. Colonoscopic surveillance in long-standing total ulcerative colitis-a 15-year follow-up study. Gastroenterology. 1990 Oct;99 (4):1021-31.","DOI":"10.1016\/0016-5085(90)90622-8"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Lutgens MW, Oldenburg B, Siersema PD, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009 Nov 17;101 (10):1671-5.","DOI":"10.1038\/sj.bjc.6605359"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000 Feb;14 (2):145-53.","DOI":"10.1046\/j.1365-2036.2000.00698.x"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Ananthakrishnan AN, Cagan A, Cai T, et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2015 Feb;13 (2):322-9.e1.","DOI":"10.1016\/j.cgh.2014.07.018"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Farraye FA, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb;138 (2):746-74, 774:e1-4.","DOI":"10.1053\/j.gastro.2009.12.035"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Itzkowitz SH, Present DH, Crohn&apos;s and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005 Mar;11 (3):314-21.","DOI":"10.1097\/01.MIB.0000160811.76729.d5"},{"key":"70","unstructured":"70. American Society for Gastrointestinal Endoscopy Standards of Practice Committee; Shergill AK, Lightdale JR, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015 May;81 (5):1101-21.e1-13."},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010 Mar;105 (3):501-24.","DOI":"10.1038\/ajg.2009.727"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010 May;59 (5):666-89.","DOI":"10.1136\/gut.51.suppl_5.v1"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013 Dec;7 (12):982-1018.","DOI":"10.1016\/j.crohns.2013.09.016"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015 Mar;148 (3):639-51.e28.","DOI":"10.1053\/j.gastro.2015.01.031"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Bye WA, Nguyen TM, Parker CE, et al. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2017 Sep 18;9 (9):CD000279.","DOI":"10.1002\/14651858.CD000279.pub4"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Choi PM, Nugent FW, Schoetz DJ Jr, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993 Aug;105 (2):418-24.","DOI":"10.1016\/0016-5085(93)90715-O"},{"key":"77","unstructured":"77. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol. 1990 Sep;85 (9):1083-7."},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Rabbenou W, Ullman TA. Risk of colon cancer and recommended surveillance strategies in patients with ulcerative colitis. Gastroenterol Clin North Am. 2020 Dec;49 (4):791-807.","DOI":"10.1016\/j.gtc.2020.08.005"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Lindberg BU, Broom\u00e9 U, Persson B. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Dis Colon Rectum. 2001 Jan;44 (1):77-85.","DOI":"10.1007\/BF02234825"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Sengupta N, Yee E, Feuerstein JD. Colorectal cancer screening in inflammatory bowel disease. Dig Dis Sci. 2016 Apr;61 (4):980-9.","DOI":"10.1007\/s10620-015-3979-z"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Kim HS, Hernaez R, Sansgiry S, et al. Comparative effectiveness of surveillance colonoscopy intervals on colorectal cancer outcomes in a national cohort of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2022 Dec;20 (12):2848-57.e2.","DOI":"10.1016\/j.cgh.2022.02.048"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Stolwijk JA, Langers AM, Hardwick JC, et al. A thirty-year follow-up surveillance study for neoplasia of a Dutch ulcerative colitis cohort. ScientificWorldJournal. 2013 Nov 28;2013:274715.","DOI":"10.1155\/2013\/274715"},{"key":"83","unstructured":"83. Sekra A, Schauer C, Mills L, et al. Chromoendoscopy versus standard colonoscopy for detection of nonpolypoid dysplasia in patients with inflammatory bowel disease. N Z Med J. 2018 Jul 13;131 (1478):32-8."},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Moussata D, Allez M, Cazals-Hatem D, et al. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. 2018 Apr;67 (4):616-24.","DOI":"10.1136\/gutjnl-2016-311892"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Bisschops R, Bessissow T, Joseph JA, et al. Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial. Gut. 2018 Jun;67 (6):1087-94.","DOI":"10.1136\/gutjnl-2016-313213"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Iannone A, Ruospo M, Wong G, et al. Chromoendoscopy for surveillance in ulcerative colitis and Crohn&apos;s disease: a systematic review of randomized trials. Clin Gastroenterol Hepatol. 2017 Nov;15 (11):1684-97.e11.","DOI":"10.1016\/j.cgh.2016.11.021"},{"key":"87","unstructured":"87. Sugita A. Evaluation of a Surveillance Program for Anorectal Cancer (including fistula-associated cancer) in Crohn&apos;s disease. Report on a grant from the Ministry of Health, Labour and Welfare (Research Project on Intractable Diseases): research on intractable inflammatory bowel diseases (co-investigator&apos;s report); 2020. (Japanese). Characteristics and prognosis of small and large intestinal cancers associated with ulcerative colitis and Crohn&apos;s disease - Report No. 15."},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Yoshizawa S, Matsuoka K, Inoue N, et al. Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis. Inflamm Bowel Dis. 2007 Jul;13 (7):865-73.","DOI":"10.1002\/ibd.20112"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Hirano Y, Futami K, Higashi D, et al. Anorectal cancer surveillance in Crohn&apos;s disease. J Anus Rectum Colon. 2018 Oct 29;2 (4):145-54.","DOI":"10.23922\/jarc.2018-005"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Viennot S, Deleporte A, Moussata D, et al. Colon cancer in inflammatory bowel disease: recent trends, questions and answers. Gastroenterol Clin Biol. 2009 Jun:33 (suppl 3):S190-201.","DOI":"10.1016\/S0399-8320(09)73154-9"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Johnson DH, Taylor WR, Aboelsoud MM, et al. DNA methylation and mutation of small colonic neoplasms in ulcerative colitis and Crohn&apos;s colitis: implications for surveillance. Inflamm Bowel Dis. 2016 Jul;22 (7):1559-67.","DOI":"10.1097\/MIB.0000000000000795"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Mooiweer E, Fidder HH, Siersema PD, et al. Fecal calprotectin testing can identify ineffective colorectal cancer surveillance procedures in patients with longstanding colitis. Inflamm Bowel Dis. 2014 Jun;20 (6):1079-84.","DOI":"10.1097\/MIB.0000000000000054"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Eaden J, Abrams K, Shears J, et al. Randomized controlled trial comparing the efficacy of a video and information leaflet versus information leaflet alone on patient knowledge about surveillance and cancer risk in ulcerative colitis. Inflamm Bowel Dis. 2002 Nov;8 (6):407-12.","DOI":"10.1097\/00054725-200211000-00005"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Watanabe T, Ajioka Y, Mitsuyama K, et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology. 2016 Dec;151 (6):1122-30.","DOI":"10.1053\/j.gastro.2016.08.002"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Watanabe K, Hida N, Ajioka Y, et al. Photodynamic diagnosis of endoscopically invisible flat dysplasia in patients with ulcerative colitis by visualization using local 5-aminolevulinic acid-induced photosensitization. Gastrointest Endosc. 2010 May;71 (6):1094-6.","DOI":"10.1016\/j.gie.2009.10.016"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Hata K, Ishihara S, Ajioka Y, et al. Long-term follow-up of targeted biopsy yield (LOFTY study) in ulcerative colitis surveillance colonoscopy. J Clin Med. 2020 Jul 18;9 (7):2286.","DOI":"10.3390\/jcm9072286"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Torres J, Caprioli F, Katsanos KH, et al. Predicting outcomes to optimize disease management in inflammatory bowel diseases. J Crohns Colitis. 2016 Dec;10 (12):1385-94.","DOI":"10.1093\/ecco-jcc\/jjw116"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Ueda T, Inoue T, Nakamoto T, et al. Anorectal cancer in Crohn&apos;s disease has a poor prognosis due to its advanced stage and aggressive histological features: a systematic literature review of Japanese patients. J Gastrointest Cancer. 2020 Mar;51 (1):1-9.","DOI":"10.1007\/s12029-018-0180-6"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn&apos;s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994 Jul;35 (7):950-4.","DOI":"10.1136\/gut.35.7.950"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Stahl TJ, Schoetz DJ Jr, Roberts PL, et al. Crohn&apos;s disease and carcinoma: increasing justification for surveillance? Dis Colon Rectum. 1992 Sep;35 (9):850-6.","DOI":"10.1007\/BF02047872"},{"key":"101","unstructured":"101. Higashi D, Katsuno H, Kimura H, et al. Current state of and problems related to cancer of the intestinal tract associated with Crohn&apos;s disease in Japan. Anticancer Res. 2016 Jul;36 (7):3761-6."},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013 Feb;7 (1):1-33.","DOI":"10.1016\/j.crohns.2012.09.005"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Matsumoto T, Iwao Y, Igarashi M, et al. Endoscopic and Chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. Inflamm Bowel Dis. 2008 Feb;14 (2):259-64.","DOI":"10.1002\/ibd.20267"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Farraye FA, Odze RD, Eaden J, et al. AGA Medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb;138 (2):738-45.","DOI":"10.1053\/j.gastro.2009.12.037"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. Hata K, Watanabe T, Kazama S, et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer. 2003 Oct 6;89 (7):1232-6.","DOI":"10.1038\/sj.bjc.6601247"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. Ikeuchi H, Nakano H, Uchino M, et al. Usefulness of FDG-PET for Crohn&apos;s disease. Nippon Daicho Komonbyo Gakkai Zasshi. 2008 Oct;61 (6):303-10. Japanese.","DOI":"10.3862\/jcoloproctology.61.303"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Delbeke D, Martin WH. PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med. 2004 Jul;34 (3):209-23.","DOI":"10.1053\/j.semnuclmed.2004.03.006"},{"key":"108","unstructured":"108. Sato M, Ogawa H, Shibata C, et al. A case of anal cancer with rapidly rising CEA in longstanding perianal Crohn disease after infliximab administration. Nihon Shokakibyo Gakkai Zasshi. 2010 Jun;107 (6):885-92. Japanese."},{"key":"109","doi-asserted-by":"crossref","unstructured":"109. Yano Y, Matsui T, Uno H, et al. Risks and clinical features of colorectal cancer complicating Crohn&apos;s disease in Japanese patients. J Gastroenterol Hepatol. 2008 Nov;23 (11):1683-8.","DOI":"10.1111\/j.1440-1746.2008.05532.x"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110. Marzo M, Felice C, Pugliese D, et al. Management of perianal fistulas in Crohn&apos;s disease: an up-to-date review. World J Gastroenterol. 2015 Feb 7;21 (5):1394-403.","DOI":"10.3748\/wjg.v21.i5.1394"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111. Kudo S, Hirota S, Nakajima T, et al. Colorectal tumours and pit pattern. J Clin Pathol. 1994 Oct;47 (10):880-5.","DOI":"10.1136\/jcp.47.10.880"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112. Sano Y, Tanaka S, Kudo SE, et al. Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Dig Endosc. 2016 Jul;28 (5):526-33.","DOI":"10.1111\/den.12644"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. Iacucci M, Cannatelli R, Tontini GE, et al. Improving the quality of surveillance colonoscopy in inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2019 Dec;4 (12):971-83.","DOI":"10.1016\/S2468-1253(19)30194-3"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. Nishiyama S, Oka S, Tanaka S, et al. Clinical usefulness of narrow band imaging magnifying colonoscopy for assessing ulcerative colitis-associated cancer\/dysplasia. Endosc Int Open. 2016 Nov;4 (11):E1183-7.","DOI":"10.1055\/s-0042-116488"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115. Watanabe K, Sogawa M, Yamagami H, et al. Endoscopic differential diagnosis between ulcerative colitis-associated neoplasia and sporadic neoplasia in surveillance colonoscopy using narrow band imaging. Dig Endosc. 2011 May:23 (suppl 1):143-9.","DOI":"10.1111\/j.1443-1661.2011.01135.x"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116. Mutaguchi M, Naganuma M, Sugimoto S, et al. Difference in the clinical characteristic and prognosis of colitis-associated cancer and sporadic neoplasia in ulcerative colitis patients. Dig Liver Dis. 2019 Sep;51 (9):1257-64.","DOI":"10.1016\/j.dld.2019.05.003"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117. Iacucci M, McQuaid K, Gui XS, et al. A multimodal (FACILE) classification for optical diagnosis of inflammatory bowel disease associated neoplasia. Endoscopy. 2019 Feb;51 (2):133-41.","DOI":"10.1055\/a-0757-7759"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118. Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an Update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021 Apr;160 (5):1570-83.","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119. Shinagawa T, Hata K, Morikawa T, et al. Pine-cone and villi patterns are endoscopic signs suggestive of ulcerative colitis-associated colorectal cancer and dysplasia. Gastrointest Endosc. 2019 Mar;89 (3):565-75.e3.","DOI":"10.1016\/j.gie.2018.09.037"},{"key":"120","doi-asserted-by":"crossref","unstructured":"120. Murthy SK, Feuerstein JD, Nguyen GC, et al. AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review. Gastroenterology. 2021 Sep;161 (3):1043-51.e4.","DOI":"10.1053\/j.gastro.2021.05.063"},{"key":"121","doi-asserted-by":"crossref","unstructured":"121. Gui X, Iacucci M, Ghosh S, et al. Revisiting the distinct histomorphologic features of inflammatory bowel disease-associated neoplastic precursor lesions in the SCENIC and post-DALM Era. Hum Pathol. 2020 Jun:100:24-37.","DOI":"10.1016\/j.humpath.2020.04.010"},{"key":"122","doi-asserted-by":"crossref","unstructured":"122. Lang-Schwarz C, Adler W, Geppert M, et al. Sporadic adenoma or ulcerative colitis associated neoplasia? The endoscopist&apos;s information has an impact on diagnosis and patient management. Pathol Res Pract. 2020 Nov;216 (11):153162.","DOI":"10.1016\/j.prp.2020.153162"},{"key":"123","unstructured":"123. Parian AM, Lazarev MG. Serrated colorectal lesions in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2018 Jan;14 (1):19-25."},{"key":"124","doi-asserted-by":"crossref","unstructured":"124. Muto T, Wakasa T, Kina I, et al. Histopathological criteria for dysplasia in ulcerative colitis: proposal of new diagnostic criteria for application in surveillance colonoscopy. J Jpn Soc Coloproctol. 1994;47:547-51. Japanese.","DOI":"10.3862\/jcoloproctology.47.547"},{"key":"125","unstructured":"125. Ajioka Y, Tani Y, Takamura K, et al. [Topics in colorectal cancer Pathological diagnosis and carcinogenic mechanisms of inflammation-associated colorectal cancer. Byori to Rinsho]. 2018;36:1076-81. Japanese."},{"key":"126","doi-asserted-by":"crossref","unstructured":"126. Allende D, Elmessiry M, Hao W, et al. Inter-observer and intra-observer variability in the diagnosis of dysplasia in patients with inflammatory bowel disease: correlation of pathological and endoscopic findings. Colorectal Dis. 2014 Sep;16 (9):710-8.","DOI":"10.1111\/codi.12667"},{"key":"127","doi-asserted-by":"crossref","unstructured":"127. Eaden J, Abrams K, McKay H, et al. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol. 2001 Jun;194 (2):152-7.","DOI":"10.1002\/path.876"},{"key":"128","doi-asserted-by":"crossref","unstructured":"128. Blackstone MO, Riddell RH, Rogers BH, et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981 Feb;80 (2):366-74.","DOI":"10.1016\/0016-5085(81)90727-7"},{"key":"129","doi-asserted-by":"crossref","unstructured":"129. Lashner BA, Shapiro BD, Husain A, et al. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am J Gastroenterol. 1999 Feb;94 (2):456-62.","DOI":"10.1111\/j.1572-0241.1999.877_f.x"},{"key":"130","doi-asserted-by":"crossref","unstructured":"130. Hirsch D, Wangsa D, Zhu YJ, et al. Dynamics of genome alterations in Crohn&apos;s disease-associated colorectal carcinogenesis. Clin Cancer Res. 2018 Oct 15;24 (20):4997-5011.","DOI":"10.1158\/1078-0432.CCR-18-0630"},{"key":"131","unstructured":"131. Ajioka Y, Iwanaga A, Watanabe J, et al. Carcinogenesis and tumor progression in inflammatory bowel disease: histogenesis of colorectal cancer in ulcerative colitis. Stomach and Intestine (I to Cho). 2008;43:1935-46. Japanese."},{"key":"132","doi-asserted-by":"crossref","unstructured":"132. Du L, Kim JJ, Shen J, et al. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis. Oncotarget. 2017 Mar 28;8 (13):22175-86.","DOI":"10.18632\/oncotarget.14549"},{"key":"133","doi-asserted-by":"crossref","unstructured":"133. Lu X, Yu Y, Tan S. p53 expression in patients with ulcerative colitis-associated with dysplasia and carcinoma: a systematic meta-analysis. BMC Gastroenterol. 2017 Oct 25;17 (1):111.","DOI":"10.1186\/s12876-017-0665-y"},{"key":"134","doi-asserted-by":"crossref","unstructured":"134. Noffsinger AE, Belli JM, Miller MA, et al. A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene. Histopathology. 2001 Nov;39 (5):482-92.","DOI":"10.1046\/j.1365-2559.2001.01274.x"},{"key":"135","unstructured":"135. Yokota Y. Evaluation of p53 protein overexpression by immunohistochemistry: A study on the correlation with gene mutations [PhD thesis]. Niigata: Niigata University Graduate School of Medical and Dental Sciences; 2015. Japanese."},{"key":"136","unstructured":"136. Ajioka Y. Immunohistochemical staining for epithelial tumors: immunostaining of colorectal epithelial tumors including UC-associated tumors. Stomach and Intestine (I to Cho). 2017;52:1010-8. Japanese."},{"key":"137","doi-asserted-by":"crossref","unstructured":"137. Mikami T, Yoshida T, Akino F, et al. Apoptosis regulation differs between ulcerative colitis-associated and sporadic colonic tumors. Association with survivin and bcl-2. Am J Clin Pathol. 2003 May;119 (5):723-30.","DOI":"10.1309\/YLX4-L4H3-6K54-X92H"},{"key":"138","doi-asserted-by":"crossref","unstructured":"138. Andersen SN, Rognum TO, Bakka A, et al. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. Mol Pathol. 1998 Dec;51 (6):327-32.","DOI":"10.1136\/mp.51.6.327"},{"key":"139","doi-asserted-by":"crossref","unstructured":"139. Zivkovi\u0107 V, Petrovi\u0107 A, Dordevi\u0107 B, et al. Computer-assisted quantitative analysis of Ki-67 antigen in dysplasia--associated lesions or masses in ulcerative colitis. Vojnosanit Pregl. 2007 Nov;64 (11):753-8.","DOI":"10.2298\/VSP0711753Z"},{"key":"140","doi-asserted-by":"crossref","unstructured":"140. Mir-Madjlessi SH, Farmer RG, Easley KA, et al. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer. 1986 Oct 1;58 (7):1569-74.","DOI":"10.1002\/1097-0142(19861001)58:7<1569::AID-CNCR2820580731>3.0.CO;2-U"},{"key":"141","doi-asserted-by":"crossref","unstructured":"141. Heimann TM, Oh SC, Martinelli G, et al. Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators. Am J Surg. 1992 Jul;164 (1):13-7.","DOI":"10.1016\/S0002-9610(05)80638-5"},{"key":"142","doi-asserted-by":"crossref","unstructured":"142. Sigel JE, Petras RE, Lashner BA, et al. Intestinal adenocarcinoma in Crohn&apos;s disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol. 1999 Jun;23 (6):651-5.","DOI":"10.1097\/00000478-199906000-00003"},{"key":"143","doi-asserted-by":"crossref","unstructured":"143. Suzuki K, Watanabe T, Hata K, et al. Colorectal cancer and surveillance in patients with ulcerative colitis: the Japanese Study. J Jpn Soc Coloproctol. 2003 Oct;56:62-8. Japanese.","DOI":"10.3862\/jcoloproctology.56.62"},{"key":"144","doi-asserted-by":"crossref","unstructured":"144. Shinozaki M. Crohn&apos;s disease and intestinal cancer in Japan. J Jpn Soc Coloproctol. 2008 Oct;61:353-63. Japanese.","DOI":"10.3862\/jcoloproctology.61.353"},{"key":"145","doi-asserted-by":"crossref","unstructured":"145. Sasaki H, Ikeuchi H, Bando T, et al. Clinicopathological characteristics of cancer associated with Crohn&apos;s disease. Surg Today. 2017 Jan;47 (1):35-41.","DOI":"10.1007\/s00595-016-1336-2"},{"key":"146","unstructured":"146. Ajioka Y. Pathological diagnosis of the early lesions of ulcerative colitis-associated carcinogenesis - current status and problems. Nihon Shokakibyo Gakkai Zasshi. 2020 Jan;117 (11):957-64. Japanese."},{"key":"147","doi-asserted-by":"crossref","unstructured":"147. Riddell RH. The precarcinomatous phase of ulcerative colitis. Curr Top Pathol. 1976 Oct;63:179-219.","DOI":"10.1007\/978-3-642-66481-6_6"},{"key":"148","unstructured":"148. von Herbay A, Herfarth C, Otto HF. Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimen. Z Gastroenterol. 1994 Jul;32 (7):382-8."},{"key":"149","doi-asserted-by":"crossref","unstructured":"149. Greenstein AJ, Slater G, Heimann TM, et al. A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg. 1986 Feb;203 (2):123-8.","DOI":"10.1097\/00000658-198602000-00002"},{"key":"150","doi-asserted-by":"crossref","unstructured":"150. van Leersum NJ, Aalbers AG, Snijders HS, et al. Synchronous colorectal carcinoma: a risk factor in colorectal cancer surgery. Dis Colon Rectum. 2014 Apr;57 (4):460-6.","DOI":"10.1097\/DCR.0000000000000068"},{"key":"151","doi-asserted-by":"crossref","unstructured":"151. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994 Jan 8;343 (8889):71-4.","DOI":"10.1016\/S0140-6736(94)90813-3"},{"key":"152","doi-asserted-by":"crossref","unstructured":"152. Uzzan M, Kirchgesner J, Oubaya N, et al. Risk of rectal neoplasia after colectomy and ileorectal anastomosis for ulcerative colitis. J Crohns Colitis. 2017 Aug 1;11 (8):930-5.","DOI":"10.1093\/ecco-jcc\/jjx027"},{"key":"153","doi-asserted-by":"crossref","unstructured":"153. Derikx LAAP, Nissen LHC, Smits LJT, et al. Risk of neoplasia after colectomy in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016 Jun;14 (6):798-806.e20.","DOI":"10.1016\/j.cgh.2015.08.042"},{"key":"154","doi-asserted-by":"crossref","unstructured":"154. Abdalla M, Landerholm K, Andersson P, et al. Risk of rectal cancer after colectomy for patients with ulcerative colitis: a national cohort study. Clin Gastroenterol Hepatol. 2017 Jul;15 (7):1055-60.e2.","DOI":"10.1016\/j.cgh.2016.11.036"},{"key":"155","doi-asserted-by":"crossref","unstructured":"155. Kiran RP, Nisar PJ, Goldblum JR, et al. Dysplasia associated with Crohn&apos;s colitis: segmental colectomy or more extended resection? Ann Surg. 2012 Aug;256 (2):221-6.","DOI":"10.1097\/SLA.0b013e31825f0709"},{"key":"156","doi-asserted-by":"crossref","unstructured":"156. Maser EA, Sachar DB, Kruse D, et al. High rates of metachronous colon cancer or dysplasia after segmental resection or subtotal colectomy in Crohn&apos;s colitis. Inflamm Bowel Dis. 2013 Aug;19 (9):1827-32.","DOI":"10.1097\/MIB.0b013e318289c166"},{"key":"157","doi-asserted-by":"crossref","unstructured":"157. Fichera A, McCormack R, Rubin MA, et al. Long-term outcome of surgically treated Crohn&apos;s colitis: a prospective study. Dis Colon Rectum. 2005 May;48 (5):963-9.","DOI":"10.1007\/s10350-004-0906-3"},{"key":"158","doi-asserted-by":"crossref","unstructured":"158. Tsunoda A, Talbot IC, Nicholls RJ. Incidence of dysplasia in the anorectal mucosa in patients having restorative proctocolectomy. Br J Surg. 1990 May;77 (5):506-8.","DOI":"10.1002\/bjs.1800770510"},{"key":"159","doi-asserted-by":"crossref","unstructured":"159. Sagayama K, Ikeuchi H, Nishigami T, et al. Incidence of and risk factors for dysplasia in mucosectomy area in ulcerative colitis patients undergoing restorative proctocolectomy. Int J Colorectal Dis. 2007 Apr;22 (4):439-43.","DOI":"10.1007\/s00384-006-0178-6"},{"key":"160","doi-asserted-by":"crossref","unstructured":"160. Horio Y, Uchino M, Bando T, et al. Incidence, risk factors and outcomes of cancer of the anal transitional zone in patients with ulcerative colitis. J Crohns Colitis. 2020 Nov 7;14 (11):1565-71.","DOI":"10.1093\/ecco-jcc\/jjaa089"},{"key":"161","doi-asserted-by":"crossref","unstructured":"161. Remzi FH, Fazio VW, Delaney CP, et al. Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of prospective evaluation after a minimum of ten years. Dis Colon Rectum. 2003 Jan;46 (1):6-13.","DOI":"10.1007\/s10350-004-6488-2"},{"key":"162","doi-asserted-by":"crossref","unstructured":"162. Silva-Velazco J, Stocchi L, Wu XR, et al. Twenty-year-old stapled pouches for ulcerative colitis without evidence of rectal cancer: implications for surveillance strategy? Dis Colon Rectum. 2014 Nov;57 (11):1275-81.","DOI":"10.1097\/DCR.0000000000000219"},{"key":"163","doi-asserted-by":"crossref","unstructured":"163. Hirata A, Ikeuchi H, Bando T, et al. Adenocarcinoma in the anal canal after restorative proctocolectomy with ileal J-pouch for ulcerative colitis. Nippon Shokaki Geka Gakkai zasshi. 2017;50 (6):499-505. Japanese.","DOI":"10.5833\/jjgs.2016.0140"},{"key":"164","doi-asserted-by":"crossref","unstructured":"164. Lee SW, Sonoda T, Milsom JW. Three cases of adenocarcinoma following restorative proctocolectomy with hand-sewn anastomosis for ulcerative colitis: a review of reported cases in the literature. Colorectal Dis. 2005 Nov;7 (6):591-7.","DOI":"10.1111\/j.1463-1318.2005.00794.x"},{"key":"165","doi-asserted-by":"crossref","unstructured":"165. O&apos;Connell PR, Pemberton JH, Weiland LH, et al. Does rectal mucosa regenerate after ileoanal anastomosis? Dis Colon Rectum. 1987 Jan;30 (1):1-5.","DOI":"10.1007\/BF02556908"},{"key":"166","doi-asserted-by":"crossref","unstructured":"166. Rodriguez-Sanjuan JC, Polavieja MG, Naranjo A, et al. Adenocarcinoma in an ileal pouch for ulcerative colitis. Dis Colon Rectum. 1995 Jul;38 (7):779-80.","DOI":"10.1007\/BF02048042"},{"key":"167","doi-asserted-by":"crossref","unstructured":"167. Block M, B\u00f6rjesson L, Will\u00e9n R, et al. Neoplasia in the colorectal specimens of patients with ulcerative colitis and ileal pouch-anal anastomosis-need for routine surveillance? Scand J Gastroenterol. 2015 May;50 (5):528-35.","DOI":"10.3109\/00365521.2015.1004364"},{"key":"168","doi-asserted-by":"crossref","unstructured":"168. Schluender SJ, Mei L, Yang H, et al. Can a meta-analysis answer the question: is mucosectomy and handsewn or double-stapled anastomosis better in ileal pouch-anal anastomosis? Am Surg. 2006 Oct;72 (10):912-6.","DOI":"10.1177\/000313480607201016"},{"key":"169","doi-asserted-by":"crossref","unstructured":"169. Horio Y, Uchino M, Bando T, et al. Association between higher body mass index and pouch-related complications during restorative proctocolectomy in patients with ulcerative colitis. Digestion. 2018;98 (4):257-62.","DOI":"10.1159\/000488583"},{"key":"170","doi-asserted-by":"crossref","unstructured":"170. Hardt J, Kienle P. Occult and manifest colorectal carcinoma in ulcerative colitis: how dose it influence surgical decision making? Viszeralmedizin. 2015 Aug;31 (4):252-7.","DOI":"10.1159\/000438811"},{"key":"171","doi-asserted-by":"crossref","unstructured":"171. Suzuki N, Toyonaga T, East JE. Endoscopic submucosal dissection of colitis-related dysplasia. Endoscopy. 2017 Dec;49 (12):1237-42.","DOI":"10.1055\/s-0043-114410"},{"key":"172","doi-asserted-by":"crossref","unstructured":"172. Sensi B, Bagaglini G, Bellato V, et al. Management of low rectal cancer complicating ulcerative colitis: proposal of a treatment algorithm. Cancers (Basel). 2021 May 13;13 (10):2350.","DOI":"10.3390\/cancers13102350"},{"key":"173","doi-asserted-by":"crossref","unstructured":"173. Hotta S, Shimada Y, Nakano M, et al. Feasibility of restorative proctocolectomy in patients with ulcerative colitis-associated lower rectal cancer: a retrospective study. Asian J Surg. 2019 Jan;42 (1):267-73.","DOI":"10.1016\/j.asjsur.2018.01.003"},{"key":"174","doi-asserted-by":"crossref","unstructured":"174. Merchea A, Wolff BG, Dozois EJ, et al. Clinical features and oncologic outcomes in patients with rectal cancer and ulcerative colitis: a single-institution experience. Dis Colon Rectum. 2012 Aug;55 (8):881-5.","DOI":"10.1097\/DCR.0b013e31825bf779"},{"key":"175","doi-asserted-by":"crossref","unstructured":"175. Gorfine SR, Harris MT, Bub DS, et al. Restorative proctocolectomy for ulcerative colitis complicated by colorectal cancer. Dis Colon Rectum. 2004 Aug;47 (8):1377-85.","DOI":"10.1007\/s10350-004-0588-x"},{"key":"176","doi-asserted-by":"crossref","unstructured":"176. Inoue Y, Araki T, Okugawa Y, et al. Chemoradiotherapy followed by restorative proctocolectomy with partial intersphincteric resection for advanced rectal cancer associated with ulcerative colitis: report of a case. Surg Today. 2014 Feb;44 (2):387-90.","DOI":"10.1007\/s00595-013-0558-9"},{"key":"177","unstructured":"177. Sugita A, Koganei K, Tatsumi K, et al. Management of rectal cancer including cancer in the anal fistula with Crohn&apos;s disease. Nihon Shokakibyo Gakkai Zasshi. 2013 Mar;110 (3):396-402. Japanese."},{"key":"178","unstructured":"178. Futami K, Higashi D, Futatsuki R, et al. Long-term strategy of surgical treatment for intestinal Crohn&apos;s disease in long term. Nihon Shokakibyo Gakkai Zasshi. 2011 Mar;108 (3):410-7."},{"key":"179","unstructured":"179. Treatment Guideline for Crohn&apos;s disease. Proposed diagnostic criteria and treatment for ulcerative colitis and Crohn&apos;s disease. Annual reports of 2020. Intractable diseases, the health and labour sciences research grants (chief researchers: Dr T. Hisamatsu) from the Ministry of Health, Labor and Welfare of Japan. 2021:30-6."},{"key":"180","doi-asserted-by":"crossref","unstructured":"180. Kuwahara R, Ikeuchi H, Minagawa T, et al. Clinical results following intestinal resection in 1,143 patients with Crohn disease. Jpn J Gastroenterol Surg. 2018;51 (11):671-9.","DOI":"10.5833\/jjgs.2017.0203"},{"key":"181","doi-asserted-by":"crossref","unstructured":"181. Higashi D, Futami K, Egawa Y, et al. Prevention and countermeasures for suture failure in patient with Crohn&apos;s disease. J Jpn Soc Coloproctol. 2009;62 (10):818-22.","DOI":"10.3862\/jcoloproctology.62.818"},{"key":"182","doi-asserted-by":"crossref","unstructured":"182. Kuroki H, Sugita A, Koganei K, et al. Clinicopathological and prognostic evaluations of anorectal cancer after fecal diversion for patients with Crohn&apos;s disease. BMC Gastroenterol. 2021 Apr 13;21 (1):168.","DOI":"10.1186\/s12876-021-01751-3"},{"key":"183","doi-asserted-by":"crossref","unstructured":"183. Widmar M, Greenstein AJ, Sachar DB, et al. Small bowel adenocarcinoma in Crohn&apos;s disease. J Gastrointest Surg. 2011 May;15 (5):797-802.","DOI":"10.1007\/s11605-011-1441-x"},{"key":"184","doi-asserted-by":"crossref","unstructured":"184. Hussain T, Jeganathan NA, Karagkounis G, et al. Small bowel adenocarcinoma in Crohn&apos;s disease: a rare but devastating complication. Tech Coloproctol. 2020 Oct;24 (10):1055-62.","DOI":"10.1007\/s10151-020-02269-8"},{"key":"185","doi-asserted-by":"crossref","unstructured":"185. Wieghard N, Mongoue-Tchokote S, Young JI, et al. Prognosis of small bowel adenocarcinoma in Crohn&apos;s disease compares favourably with de novo small bowel adenocarcinoma. Colorectal Dis. 2017 May;19 (5):446-55.","DOI":"10.1111\/codi.13531"},{"key":"186","doi-asserted-by":"crossref","unstructured":"186. Fields AC, Hu FY, Lu P, et al. Small bowel adenocarcinoma: is there a difference in survival for Crohn&apos;s versus sporadic cases? J Crohns Colitis. 2020 Mar 13;14 (3):303-8.","DOI":"10.1093\/ecco-jcc\/jjz157"},{"key":"187","doi-asserted-by":"crossref","unstructured":"187. Svrcek M, Piton G, Cosnes J, et al. Small bowel adenocarcinomas complicating Crohn&apos;s disease are associated with dysplasia: a pathological and molecular study. Inflamm Bowel Dis. 2014 Sep;20 (9):1584-92.","DOI":"10.1097\/MIB.0000000000000112"},{"key":"188","doi-asserted-by":"crossref","unstructured":"188. Cahill C, Gordon PH, Petrucci A, et al. Small bowel adenocarcinoma and Crohn&apos;s disease: any further ahead than 50 years ago? World J Gastroenterol. 2014 Sep 7;20 (33):11486-95.","DOI":"10.3748\/wjg.v20.i33.11486"},{"key":"189","doi-asserted-by":"crossref","unstructured":"189. Spinelli A, Bonovas S, Burisch J, et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. J Crohns Colitis. 2022 Feb 23;16 (2):179-89.","DOI":"10.1093\/ecco-jcc\/jjab177"},{"key":"190","doi-asserted-by":"crossref","unstructured":"190. Holubar SD, Lightner AL, Poylin V, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative Colitis. Dis Colon Rectum. 2021 Jul 1;64 (7):783-804.","DOI":"10.1097\/DCR.0000000000002037"},{"key":"191","unstructured":"191. Academic Committee of the Japan Society for Endoscopic Surgery (JSES). Tokyo: General Incorporated Association Japan Society for Endoscopic Surgery; 2021. The 15th national survey of endoscopic surgery: report on the results of the survey; p. 149. Japanese."},{"key":"192","unstructured":"192. Japanese Society for Cancer of the Colon and Rectum. Edition. Tokyo: Kanehara Shuppan; 2020. Hereditary colorectal cancer; p. 133. (Japanese) Guideline 2020."},{"key":"193","unstructured":"193. Japan Society for Endoscopic Surgery. Endoscopic surgery guidelines for certified surgeons; 2019 Edition. Japanese."},{"key":"194","doi-asserted-by":"crossref","unstructured":"194. Singh P, Bhangu A, Nicholls RJ, et al. A systematic review and meta-analysis of laparoscopic vs open restorative proctocolectomy. Colorectal Dis. 2013 Jul;15 (7):e340-51.","DOI":"10.1111\/codi.12231"},{"key":"195","doi-asserted-by":"crossref","unstructured":"195. Hull TL, Joyce MR, Geisler DP, et al. Adhesions after laparoscopic and open ileal pouch-anal anastomosis surgery for ulcerative colitis. Br J Surg. 2012 Feb;99 (2):270-5.","DOI":"10.1002\/bjs.7759"},{"key":"196","doi-asserted-by":"crossref","unstructured":"196. Lavryk OA, Stocchi L, Ashburn JH, et al. Case-matched comparison of long-term functional and quality of life outcomes following laparoscopic versus open ileal pouch-anal anastomosis. World J Surg. 2018 Nov;42 (11):3746-54.","DOI":"10.1007\/s00268-018-4602-1"},{"key":"197","doi-asserted-by":"crossref","unstructured":"197. Flynn J, Larach JT, Kong JCH, et al. Robotic versus laparoscopic ileal pouch-anal anastomosis (IPAA): a systematic review and meta-analysis. Int J Colorectal Dis. 2021 Jul;36 (7):1345-56.","DOI":"10.1007\/s00384-021-03868-z"},{"key":"198","doi-asserted-by":"crossref","unstructured":"198. Lightner AL, Grass F, McKenna NP, et al. Short-term postoperative outcomes following robotic versus laparoscopic ileal pouch-anal anastomosis are equivalent. Tech Coloproctol. 2019 Mar;23 (3):259-66.","DOI":"10.1007\/s10151-019-01953-8"},{"key":"199","doi-asserted-by":"crossref","unstructured":"199. Chandrasinghe P, Carvello M, Wasmann K, et al. Transanal ileal pouch-anal anastomosis for ulcerative colitis has comparable long-term functional outcomes to transabdominal approach: A Multicentre Comparative Study. J Crohns Colitis. 2020 Jul 9;14 (6):726-33.","DOI":"10.1093\/ecco-jcc\/jjz174"},{"key":"200","doi-asserted-by":"crossref","unstructured":"200. Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of Stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA. 2015 Oct 6;314 (13):1346-55.","DOI":"10.1001\/jama.2015.10529"},{"key":"201","doi-asserted-by":"crossref","unstructured":"201. Stevenson ARL, Solomon MJ, Lumley JW, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA. 2015 Oct 6;314 (13):1356-63.","DOI":"10.1001\/jama.2015.12009"},{"key":"202","unstructured":"202. Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCO-ESCP consensus on surgery for Crohn&apos;s disease. J Crohns Colitis. 2018 Jan 5;12 (1):1-16."},{"key":"203","doi-asserted-by":"crossref","unstructured":"203. Lightner AL, Vogel JD, Carmichael JC, et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the surgical management of Crohn&apos;s disease. Dis Colon Rectum. 2020 Aug;63 (8):1028-52.","DOI":"10.1097\/DCR.0000000000001716"},{"key":"204","doi-asserted-by":"crossref","unstructured":"204. Maartense S, Dunker MS, Slors JFM, et al. Laparoscopic-assisted versus open ileocolic resection for Crohn&apos;s disease: a randomized trial. Ann Surg. 2006 Feb;243 (2):143-53.","DOI":"10.1097\/01.sla.0000197318.37459.ec"},{"key":"205","doi-asserted-by":"crossref","unstructured":"205. Milsom JW, Hammerhofer KA, B\u00f6hm B, et al. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn&apos;s disease. Dis Colon Rectum. 2001 Jan;44 (1):1-9.","DOI":"10.1007\/BF02234810"},{"key":"206","doi-asserted-by":"crossref","unstructured":"206. Raskin ER, Gorrepati ML, Mehendale S, et al. Robotic-assisted ileocolic resection for Crohn&apos;s disease: outcomes from an early national experience. J Robot Surg. 2019 Jun;13 (3):429-34.","DOI":"10.1007\/s11701-018-0887-1"},{"key":"207","doi-asserted-by":"crossref","unstructured":"207. Tran TB, Qadan M, Dua MM, et al. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. Surgery. 2015 Aug;158 (2):486-93.","DOI":"10.1016\/j.surg.2015.03.048"},{"key":"208","doi-asserted-by":"crossref","unstructured":"208. Kitano S, Inomata M, Mizusawa J, et al. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol. 2017 Apr;2 (4):261-8.","DOI":"10.1016\/S2468-1253(16)30207-2"},{"key":"209","doi-asserted-by":"crossref","unstructured":"209. Bonjer HJ, Deijen CL, Haglind E, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015 Jul 9;373 (2):194.","DOI":"10.1056\/NEJMc1505367"},{"key":"210","doi-asserted-by":"crossref","unstructured":"210. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015 Mar;81 (3):489-501.e26.","DOI":"10.1016\/j.gie.2014.12.009"},{"key":"211","unstructured":"211. Matsumoto K, Kawasaki K. Surveillance for ulcerative colitis-overview and issues of the SCENIC international consensus statement. Itocho. 2020;55:191-9. Japanese."},{"key":"212","doi-asserted-by":"crossref","unstructured":"212. Tanaka S, Kashida H, Saito Y, et al. Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection\/endoscopic mucosal resection. Dig Endosc. 2020 Jan;32 (2):219-39.","DOI":"10.1111\/den.13545"},{"key":"213","doi-asserted-by":"crossref","unstructured":"213. Kinoshita S, Nishizawa T, Yahagi N, et al. Endoscopic submucosal dissection in patients with ulcerative colitis. Digestion. 2019;99 (1):27-32.","DOI":"10.1159\/000494409"},{"key":"214","unstructured":"214. Uraoka T, Hashimoto Y, Sato K, et al. Endoscopic treatment for ulcerative colitis-associated tumors-my perspective. Itocho. 2020;55:170-1. Japanese."},{"key":"215","doi-asserted-by":"crossref","unstructured":"215. Iacopini F, Saito Y, Yamada M, et al. Curative endoscopic submucosal dissection of large nonpolypoid superficial neoplasms in ulcerative colitis (with videos). Gastrointest Endosc. 2015;82 (4):734-8.","DOI":"10.1016\/j.gie.2015.02.052"},{"key":"216","doi-asserted-by":"crossref","unstructured":"216. Kinoshita S, Uraoka T, Nishizawa T, et al. The role of colorectal endoscopic submucosal dissection in patients with ulcerative colitis. Gastrointest Endosc. 2018 Apr;87 (4):1079-84.","DOI":"10.1016\/j.gie.2017.10.035"},{"key":"217","doi-asserted-by":"crossref","unstructured":"217. Yang DH, Kim J, Song EM, et al. Outcomes of ulcerative colitis-associated dysplasia patients referred for potential endoscopic submucosal dissection. J Gastroenterol Hepatol. 2019 Sep;34 (9):1581-9.","DOI":"10.1111\/jgh.14623"},{"key":"218","doi-asserted-by":"crossref","unstructured":"218. Matsumoto K, Oka S, Tanaka S, et al. Long-term outcomes after endoscopic submucosal dissection for ulcerative colitis-associated dysplasia. Digestion. 2021;102 (2):205-15.","DOI":"10.1159\/000503341"},{"key":"219","doi-asserted-by":"crossref","unstructured":"219. Manta R, Zullo A, Telesca DA, et al. Endoscopic submucosal dissection for visible dysplasia treatment in ulcerative colitis patients: cases series and systematic review of literature. J Crohns Colitis. 2021 Jan 13;15 (1):165-8.","DOI":"10.1093\/ecco-jcc\/jjaa158"},{"key":"220","doi-asserted-by":"crossref","unstructured":"220. Yoshii S, Shinzaki S, Hayashi Y, et al. Endoscopic submucosal dissection for remnant rectal neoplasm after ileal pouch-anal anastomosis for ulcerative colitis. Endoscopy. 2019 Dec;51 (12):E406-7.","DOI":"10.1055\/a-0950-9501"},{"key":"221","doi-asserted-by":"crossref","unstructured":"221. Chen W, Zhang YL, Zhao Y, et al. Endoscopic resection for non-polypoid dysplasia in inflammatory bowel disease: a systematic review and meta-analysis. Surg Endosc. 2021 Apr;35 (4):1534-43.","DOI":"10.1007\/s00464-020-08225-9"},{"key":"222","doi-asserted-by":"crossref","unstructured":"222. Wanders LK, Dekker E, Pullens B, et al. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol. 2014 May;12 (5):756-64.","DOI":"10.1016\/j.cgh.2013.07.024"},{"key":"223","doi-asserted-by":"crossref","unstructured":"223. Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs. 2007;67 (8):1167-98.","DOI":"10.2165\/00003495-200767080-00006"},{"key":"224","doi-asserted-by":"crossref","unstructured":"224. Axelrad J, Bernheim O, Colombel JF, et al. Risk of new or recurrent cancer in patients with inflammatory bowel disease and previous cancer exposed to immunosuppressive and anti-tumor necrosis factor agents. Clin Gastroenterol Hepatol. 2016 Jan;14 (1):58-64.","DOI":"10.1016\/j.cgh.2015.07.037"},{"key":"225","doi-asserted-by":"crossref","unstructured":"225. Shelton E, Laharie D, Scott FI, et al. Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis. Gastroenterology. 2016 Jul;151 (1):97-109.e4.","DOI":"10.1053\/j.gastro.2016.03.037"},{"key":"226","doi-asserted-by":"crossref","unstructured":"226. Micic D, Komaki Y, Alavanja A, et al. Risk of cancer recurrence among individuals exposed to antitumor necrosis factor therapy: a systematic review and meta-analysis of observational studies. J Clin Gastroenterol. 2019 Jan;53 (1):e1-11.","DOI":"10.1097\/MCG.0000000000000865"},{"key":"227","doi-asserted-by":"crossref","unstructured":"227. Jensen A\u00d8, Thomsen HF, Engebjerg MC, et al. Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin&apos;s lymphoma: a population-based case-control study. Br J Cancer. 2009;100:200-5.","DOI":"10.1038\/sj.bjc.6604796"},{"key":"228","doi-asserted-by":"crossref","unstructured":"228. S\u00f8rensen HT, Mellemkjaer L, Nielsen GL, et al. Skin cancers and non-Hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst. 2004 May 5;96 (9):709-11.","DOI":"10.1093\/jnci\/djh118"},{"key":"229","doi-asserted-by":"crossref","unstructured":"229. Radice E, Nelson H, Devine RM, et al. Ileal pouch-anal anastomosis in patients with colorectal cancer: long-term functional and oncologic outcomes. Dis Colon Rectum. 1998 Jan;41 (1):11-7.","DOI":"10.1007\/BF02236889"},{"key":"230","doi-asserted-by":"crossref","unstructured":"230. Oua\u00efssi M, Maggiori L, Alves A, et al. Colorectal cancer complicating inflammatory bowel disease: a comparative study of Crohn&apos;s disease vs ulcerative colitis in 34 patients. Colorectal Dis. 2011 Jun;13 (6):684-8.","DOI":"10.1111\/j.1463-1318.2010.02241.x"},{"key":"231","doi-asserted-by":"crossref","unstructured":"231. Alsughayer A, Grass F, McKenna NP, et al. Does IBD portend worse outcomes in patients with rectal cancer? A case-matched analysis IBID. Dis Colon Rectum. 2020;63 (9):1265-75.","DOI":"10.1097\/DCR.0000000000001666"},{"key":"232","doi-asserted-by":"crossref","unstructured":"232. Nio K, Higashi D, Kumagai H, et al. Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in Japan. Anti Cancer Drugs. 2016 Jun;27 (5):457-63.","DOI":"10.1097\/CAD.0000000000000338"},{"key":"233","doi-asserted-by":"crossref","unstructured":"233. Coelho R, Silva M, Gaspar R, et al. &quot;A book should not be judged by its cover&quot;: two cases of intestinal adenocarcinoma as the first manifestation of Crohn&apos;s disease. Int J Colorectal Dis. 2016 May;31 (5):1061-2.","DOI":"10.1007\/s00384-015-2389-1"},{"key":"234","unstructured":"234. Japanese Society for Cancer of the Colon and Rectum (JSCCR). Japanese guidelines for the treatment of colorectal cancer; 2019 Edition. Tokyo: Kanehara Shuppan; 2019. Japanese."},{"key":"235","doi-asserted-by":"crossref","unstructured":"235. Yaeger R, Paroder V, Bates DDB, et al. Systemic chemotherapy for metastatic colitis-associated cancer has a worse outcome than sporadic colorectal cancer: Matched case cohort analysis. Clin Colorectal Cancer. 2020 Dec;19 (4):e151-6.","DOI":"10.1016\/j.clcc.2020.02.008"},{"key":"236","doi-asserted-by":"crossref","unstructured":"236. Axelrad J, Kriplani A, Ozbek U, et al. Chemotherapy tolerance and oncologic outcomes in patients with colorectal cancer with and without inflammatory bowel disease. Clin Colorectal Cancer. 2017 Sep;16 (3):e205-10.","DOI":"10.1016\/j.clcc.2016.09.005"},{"key":"237","doi-asserted-by":"crossref","unstructured":"237. Luo C, Cen S, Ding G, et al. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond). 2019 Mar 29;39 (1):13.","DOI":"10.1186\/s40880-019-0361-0"},{"key":"238","unstructured":"238. Naito A, Mizushima T, Takeyama H, et al. Feasibility of chemotherapy in patients with inflammatory bowel disease-related gastrointestinal cancer. Hepatogastroenterology. 2014 Jun;61 (132):942-6."},{"key":"239","doi-asserted-by":"crossref","unstructured":"239. Goessling W, Mayer RJ. Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease. Gastroenterol Clin North Am. 2006 Sep;35 (3):713-27.","DOI":"10.1016\/j.gtc.2006.07.006"},{"key":"240","doi-asserted-by":"crossref","unstructured":"240. Jauregui-Amezaga A, Vermeire S, Prenen H. Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer. Ann Gastroenterol. 2016 Apr-Jun;29 (2):127-36.","DOI":"10.20524\/aog.2016.0004"},{"key":"241","doi-asserted-by":"crossref","unstructured":"241. Bosch SL, van Rooijen SJ, B\u00f6kkerink GM, et al. Acute toxicity and surgical complications after preoperative (chemo) radiation therapy for rectal cancer in patients with inflammatory bowel disease. Radiother Oncol. 2017 Apr;123 (1):147-53.","DOI":"10.1016\/j.radonc.2017.02.009"},{"key":"242","unstructured":"242. Ikeuchi H, Uchino M, Matsuoka H, et al. IBD-associated cancer in rectum and perianal lesion of Crohn&apos;s disease patients. IBID. Res. 2010;4:107-12. Japanese."},{"key":"243","unstructured":"243. Araki T, Inoue Y, Tanaka K, et al. Surgery for rectal and anal canal cancer with ulcerative colitis. Nihon Rinsho. 2012 Feb;70 (suppl 1):535-40."},{"key":"244","doi-asserted-by":"crossref","unstructured":"244. Kinoshita O, Nakanishi M, Murayama Y, et al. A Crohn&apos;s disease patient with fistula-associated anorectal cancer curatively resected after neoadjuvant chemoradiotherapy. Jpn J Gastroenterol Surg. 2013;46 (6):463-70. Japanese.","DOI":"10.5833\/jjgs.2012.0102"},{"key":"245","doi-asserted-by":"crossref","unstructured":"245. Iesalnieks I, Gaertner WB, Glass H, et al. Fistula-associated anal adenocarcinoma in Crohn&apos;s disease. Inflamm Bowel Dis. 2010 Oct;16 (10):1643-8.","DOI":"10.1002\/ibd.21228"},{"key":"246","doi-asserted-by":"crossref","unstructured":"246. Scharl M, Frei P, Frei SM, et al. Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn&apos;s disease. Eur J Gastroenterol Hepatol. 2014 Jan;26 (1):114-8.","DOI":"10.1097\/MEG.0b013e32836371a2"},{"key":"247","doi-asserted-by":"crossref","unstructured":"247. Green S, Stock RG, Greenstein AJ. Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy. Int J Radiat Oncol Biol Phys. 1999 Jul 1;44 (4):835-40.","DOI":"10.1016\/S0360-3016(99)00091-7"},{"key":"248","doi-asserted-by":"crossref","unstructured":"248. Althumairi AA, Canner JK, Gearhart SL, et al. Predictors of perineal wound complications and prolonged time to perineal wound healing after abdominoperineal resection. World J Surg. 2016 Jul;40 (7):1755-62.","DOI":"10.1007\/s00268-016-3450-0"},{"key":"249","doi-asserted-by":"crossref","unstructured":"249. Hult\u00e9n L. Conversion of a pelvic pouch to a continent pouch (Kock pouch). Tech Coloproctol. 2001 Dec;5 (3):192.","DOI":"10.1007\/s101510100025"},{"key":"250","doi-asserted-by":"crossref","unstructured":"250. Wu XR, Kiran RP, Remzi FH, et al. Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer. J Crohns Colitis. 2013 Nov;7 (10):e419-26.","DOI":"10.1016\/j.crohns.2013.01.017"},{"key":"251","doi-asserted-by":"crossref","unstructured":"251. Ali RA, Dooley C, Comber H, et al. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011 Jul;9 (7):584-9.e1-2.","DOI":"10.1016\/j.cgh.2011.04.016"},{"key":"252","doi-asserted-by":"crossref","unstructured":"252. Reynolds IS, O&apos;Toole A, Deasy J, et al. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer. Int J Colorectal Dis. 2017 Apr;32 (4):443-51.","DOI":"10.1007\/s00384-017-2754-3"},{"key":"253","doi-asserted-by":"crossref","unstructured":"253. Ou B, Zhao J, Guan S, et al. Survival of colorectal cancer in patients with or without inflammatory bowel disease: a meta-analysis. Dig Dis Sci. 2016 Mar;61 (3):881-9.","DOI":"10.1007\/s10620-015-3940-1"},{"key":"254","doi-asserted-by":"crossref","unstructured":"254. Lu C, Schardey J, Zhang T, et al. Survival outcomes and clinicopathological features in inflammatory bowel disease-associated colorectal cancer: a systematic review and meta-analysis. Ann Surg. 2022 Nov 1;276 (5):e319-30.","DOI":"10.1097\/SLA.0000000000005339"},{"key":"255","doi-asserted-by":"crossref","unstructured":"255. Ol\u00e9n O, Erichsen R, Sachs MC, et al. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. Lancet. 2020 Jan 11;395 (10218):123-31.","DOI":"10.1016\/S0140-6736(19)32545-0"},{"key":"256","doi-asserted-by":"crossref","unstructured":"256. Svrcek M, Borralho Nunes P, Villanacci V, et al. Clinicopathological and molecular specificities of inflammatory bowel disease-related colorectal neoplastic lesions: The role of inflammation. J Crohns Colitis. 2018 Nov 28;12 (12):1486-98.","DOI":"10.1093\/ecco-jcc\/jjy132"},{"key":"257","doi-asserted-by":"crossref","unstructured":"257. Yasukawa S, Matsui T, Yano Y, et al. Crohn&apos;s disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan. J Gastroenterol. 2019 Jan;54 (1):42-52.","DOI":"10.1007\/s00535-018-1482-y"},{"key":"258","doi-asserted-by":"crossref","unstructured":"258. Chin YH, Jain SR, Lee MH, et al. Small bowel adenocarcinoma in Crohn&apos;s disease: a systematic review and meta-analysis of the prevalence, manifestation, histopathology, and outcomes. Int J Colorectal Dis. 2022 Jan;37 (1):239-50.","DOI":"10.1007\/s00384-021-04050-1"},{"key":"259","doi-asserted-by":"crossref","unstructured":"259. Pedersen N, Duricova D, Elkjaer M, et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010 Jul;105 (7):1480-7.","DOI":"10.1038\/ajg.2009.760"},{"key":"260","doi-asserted-by":"crossref","unstructured":"260. Lo B, Zhao M, Vind I, et al. The risk of extraintestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2021 Jun;19 (6):1117-38.e19.","DOI":"10.1016\/j.cgh.2020.08.015"},{"key":"261","doi-asserted-by":"crossref","unstructured":"261. Trivedi PJ, Crothers H, Mytton J, et al. Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age. Gastroenterology. 2020 Sep;159 (3):915-28.","DOI":"10.1053\/j.gastro.2020.05.049"},{"key":"262","doi-asserted-by":"crossref","unstructured":"262. Askling J, Brandt L, Lapidus A, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005 May;54 (5):617-22.","DOI":"10.1136\/gut.2004.051771"},{"key":"263","doi-asserted-by":"crossref","unstructured":"263. Armstrong RG, West J, Card TR. Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study. Am J Gastroenterol. 2010 Jul;105 (7):1604-9.","DOI":"10.1038\/ajg.2009.745"},{"key":"264","doi-asserted-by":"crossref","unstructured":"264. Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009 Nov 7;374 (9701):1617-25.","DOI":"10.1016\/S0140-6736(09)61302-7"},{"key":"265","doi-asserted-by":"crossref","unstructured":"265. Lemaitre M, Kirchgesner J, Rudnichi A, et al. Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease. JAMA. 2017 Nov 7;318 (17):1679-86.","DOI":"10.1001\/jama.2017.16071"},{"key":"266","doi-asserted-by":"crossref","unstructured":"266. Kobayashi T, Uda A, Udagawa E, et al. Lack of increased risk of lymphoma by thiopurines or biologics in Japanese patients with inflammatory bowel disease: a large-scale administrative database analysis. J Crohns Colitis. 2020 Jun 19;14 (5):617-23.","DOI":"10.1093\/ecco-jcc\/jjz204"},{"key":"267","doi-asserted-by":"crossref","unstructured":"267. van den Heuvel TR, Wintjens DS, Jeuring SF, et al. Inflammatory bowel disease, cancer and medication: cancer risk in the Dutch population-based IBDSL cohort. Int J Cancer. 2016 Sep 15;139 (6):1270-80.","DOI":"10.1002\/ijc.30183"},{"key":"268","doi-asserted-by":"crossref","unstructured":"268. Yadav S, Singh S, Harmsen WS, et al. Effect of medications on risk of cancer in patients with inflammatory bowel diseases: a population-based cohort study from Olmsted County, Minnesota. Mayo Clin Proc. 2015 Jun;90 (6):738-46.","DOI":"10.1016\/j.mayocp.2015.03.024"},{"key":"269","doi-asserted-by":"crossref","unstructured":"269. Singh S, Nagpal SJ, Murad MH, et al. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12 (2):210-8.","DOI":"10.1016\/j.cgh.2013.04.033"},{"key":"270","doi-asserted-by":"crossref","unstructured":"270. Long MD, Martin CF, Pipkin CA, et al. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012 Aug;143 (2):390-9.e1.","DOI":"10.1053\/j.gastro.2012.05.004"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/1\/10_2025-071\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:39:14Z","timestamp":1769834354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/1\/10_2025-071\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":270,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2025-071","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"article-number":"2025-071"}}